EN DE
STOCK COMPARISON

INNOSTAR ORD A (SHH) EQSW Exp: vs Eli Lilly and: Fair Value & Quality

Both stocks run through our valuation models. Here is how INNOSTAR ORD A (SHH) EQSW Exp: (688710) and Eli Lilly and (LLY) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees Eli Lilly and as the less overvalued of the two: INNOSTAR ORD A (SHH) EQSW Exp: trades at ¥90.69 versus a fair value of ¥10.48 (-88%), while Eli Lilly and trades at $1,186 versus $397 (-67%).
INNOSTAR ORD A (SHH) EQSW Exp:
688710.SHG · CNY · Healthcare
-88%
upside to fair value
overvalued
Price¥90.69
Fair Value¥10.48
Quality27/100
Eli Lilly and
LLY · USD · Health Care
-67%
upside to fair value
overvalued
Price$1,186
Fair Value$397
Quality69/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

INNOSTAR ORD A (SHH) EQSW Exp:Eli Lilly and
Valuation
—P/E (TTM)42.2×
1.35×P/S (TTM)14.67×
0.47×P/B39.94×
—EV/EBITDA30.2×
—PEG1.54×
—Dividend yield0.5%
—Dividend per share$6.23
Profitability
-3%Net margin35%
11%Operating margin49%
-0%Return on equity107%
1%Return on assets21%
Growth
0%Revenue growth (YoY)56%
-2.0%Avg. growth/yr (3Y)31.7%
—Avg. growth/yr (5Y)21.6%
Balance & size
—Debt / equity1.54×
$1BMarket cap$1.1T
weakGrowth qualitymixed

Eli Lilly and leads: 2 to 6 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

INNOSTAR ORD A (SHH) EQSW Exp:of which business quality 31 · market factors 68 Eli Lilly andof which business quality 65 · market factors 81
ProfitabilityMargins and returns on capital today
10
85
Quality GrowthAre margins and returns improving?
0
86
CashflowEarnings quality: real cash, not paper profit
18
51
Fin. StrengthBalance sheet, leverage, solvency risk
83
53
InvestmentDisciplined investing over empire-building
30
15
Low VolatilityCalm price path (market factor)
0
73
MomentumPrice trend over the last 3–12 months (market factor)
95
78
52W MomentumDistance to the 52-week high (market factor)
100
92
Net IssuanceBuybacks instead of dilution
40
93

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

INNOSTAR ORD A (SHH) EQSW Exp:

Earnings-Based¥10.48
Dividend Discount¥3.82
Multiples¥12.05
Asset-Based¥11.04
Economic Profit¥10.48

8 of 8 models see the stock below the current price.

Eli Lilly and

DCF Models$334
Earnings-Based$239
Dividend Discount$115
Multiples$358
Asset-Based$19.94
Growth DCF$187
Economic Profit$347
Growth Earnings$375

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

INNOSTAR ORD A (SHH) EQSW Exp:
Bear ¥10.29Fair Value ¥10.48Bull ¥11.07
¥90.69 = current price (white tick)
Eli Lilly and
Bear $222Fair Value $397Bull $582
$1,186 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

INNOSTAR ORD A (SHH) EQSW Exp: · Healthcare

Quality score27 · bottom 25%
Fair value upside-88% · bottom 25%

Eli Lilly and · Health Care

Quality score69 · Top 25%
Fair value upside-67% · bottom 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees Eli Lilly and as the less overvalued of the two: INNOSTAR ORD A (SHH) EQSW Exp: trades at ¥90.69 versus a fair value of ¥10.48 (-88%), while Eli Lilly and trades at $1,186 versus $397 (-67%).

Eli Lilly and has the higher quality score (69/100).

See the full analysis →
INNOSTAR ORD A (SHH) EQSW Exp: · Eli Lilly and

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to INNOSTAR ORD A (SHH) EQSW Exp:

Alphabet Inc Class C vs Verizon CommunicationsAlphabet Inc Class C vs At&tAlphabet Inc Class C vs NetEaseAmazon.com vs Toyota Motor Corporation

Related to Eli Lilly and

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.